|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.180 EUR | -1.67% |
|
-1.26% | -19.73% |
| 06/07 | Laboratorio Erfo continues buyback, acquires 15,000 treasury shares | AN |
| 29/06 | Laboratorio Farmaceutico Erfo buys back 14,000 treasury shares | AN |
Business description: Laboratorio Farmaceutico Erfo S.p.A.

Number of employees: 50
Sales by Activity: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Network | - | 39.47L | 47.41L | 46.21L | 78.61L |
Direct | 6L | 5L | 7L | 9L | 10.88L |
Other | - | 5L | 6L | 6L | 7L |
Medical | - | 1L | 2L | 3L | 4L |
Revenues from Services | 1.12T | - | - | - | - |
Wholesale Sales Revenues | 40.72L | - | - | - | - |
Geographical breakdown of sales: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
ITALY | 46.63L | 50.13L | 52.28L | 53.29L | 89.59L |
France | - | - | 8L | 9L | 9L |
Belgium | - | - | 2L | 2L | 2L |
Other (EU) | - | - | 5T | - | - |
Spain | 8T | 15.4T | 5.17T | 184 | - |
Executive Committee: Laboratorio Farmaceutico Erfo S.p.A.
| Manager | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CEO | Chief Executive Officer | 56 | 01/01/2013 |
| Director of Finance/CFO | - | - |
Composition of the Board of Directors: Laboratorio Farmaceutico Erfo S.p.A.
| Director | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CHM | Chairman | 56 | 01/01/2013 |
Flavio Corpina
BRD | Director/Board Member | 47 | 01/01/2017 |
Fabio Giuffre
BRD | Director/Board Member | 45 | - |
Company details: Laboratorio Farmaceutico Erfo S.p.A.
Laboratorio Farmaceutico Erfo SpA
Viale Geki Russo, 9
98049, Tirrena
+39 09 09 14 61 25
http://www.erfo.it
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.67% | -1.26% | -8.17% | +3.51% | 1.15Cr | ||
| +0.85% | -0.80% | +54.84% | +163.70% | 1,05100Cr | ||
| +1.23% | -1.53% | +55.26% | +59.07% | 61TCr | ||
| +0.04% | +2.58% | +32.96% | +88.75% | 45TCr | ||
| +0.78% | -0.71% | +30.04% | +24.61% | 33TCr | ||
| +1.41% | +0.58% | +33.92% | +47.20% | 28TCr | ||
| -0.27% | -1.87% | +22.13% | +23.47% | 26TCr | ||
| -1.76% | +2.37% | -22.19% | -38.45% | 22TCr | ||
| -1.42% | +0.80% | +22.81% | +60.77% | 20TCr | ||
| -1.48% | +3.43% | +23.42% | +73.31% | 17TCr | ||
| Average | -0.27% | +0.36% | +24.50% | +50.59% | 35.75TCr | |
| Weighted average by Cap. | +0.22% | +0.02% | +37.75% | +81.49% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ERFO Stock
- Company Laboratorio Farmaceutico Erfo S.p.A.
Select your edition
All financial news and data tailored to specific country editions

















